The agreement allows Sysmex to distribute two Streck blood collection tubes for cell-free DNA as part of its medical diagnostics products and services.

Last week GenomeWeb's readers were most interested in Illumina's lawsuit against Oxford Nanopore.

The University of California, Berkeley, is considering closing its College of Chemistry because of budget woes.

NanoString will develop and commercialize the diagnostic test to predict response to Merck's cancer immunotherapeutic antibody Keytruda.

Under the deal, Sony DADC BioSciences will manufacture microfluidic assay cartridges for MyCartis' Evaluation system at its Salzburg, Austria facility.

Experts told FDA to account for variability in lab procedures and evolving science when regulating multi-marker NGS panel tests for cancer.

President Obama has launched a "take your child to the lab week" initiative, the AP reports.

The company credited the increased revenue to its expanded product line-up and multiple collaborations with biopharma companies to develop diagnostics.

The Wellcome Trust Sanger Institute spinout was working on combining genomic and clinical data sets to inform cancer diagnosis, prognosis, and treatment.

Fred Hutch researchers report that analysis of one metastatic prostate tumor sample captures most of the variation in an individual's various metastases.

Nasdaq said the firm is not in compliance with the $1.00 minimum bid price required for continued listing for the 30 consecutive business days leading up to Feb. 23.

Some studies seem to rehash what's long been known in a field, Nature News notes.

Genomic and transcriptomic sequence data from hundreds of mesothelioma tumors has uncovered recurrent gene mutations, gene fusions, and pathway alterations.

Using Luminex's FlexMap detector, the method allows quantification of cells in a mixture of up to hundreds of individual cells lines treated with drugs in vitro.

In PLOS this week: metabolomics signature of dengue disease progression, patterns of diversity in Pseudomonas fluorescens, and more.

The NIH has also set aside about $5.8 million in fiscal 2016 funding to support biomarker research and to set up a coordinating center for the consortium.

Clontech Laboratories, a subsidiary of Takara Bio, has released TaKaRa Taq Hot Start Version GMP Grade. The product contains Taq polymerase and a monoclonal antibody to Taq polymerase and it is suitable for a variety of PCR applications. It is manufactured in a facility compliant with GMP regulations and guidelines, and is available in custom sizes and packaging.

Rosetta Genomics has appointed Ana Ward as executive vice president of legal and corporate development. Ward most recently served as chief operating officer of Aptamir Therapeutics, a biotech startup focused on microRNA-based therapeutics. Prior to that, she was general counsel and senior vice president for Asuragen, and its spinoff Mirna Therapeutics. Ward has also served as general counsel at Ambion and senior intellectual property counsel for Yum! Brands.

The test uses a 23-gene panel to identify suspected lung cancer patients at low risk of cancer following an inconclusive bronchoscopy result.

The approach taken in the UK to approve mitochondrial replacement could inform the debate over using genome editing, a pair of researchers say in Cell.

Earlier this month at AGBT, company researchers presented the new developments, which Thermo Fisher plans to roll out later this year.

Researchers from St. Jude Children's and the German Cancer Research Center used methylation and gene expression analyses to uncover the subtypes.

In Science this week: some Cas proteins are linked to a reverse transcriptase gene, and more.

Two senators introduce a bill to better support new scientific investigators.